## Most Common Alpha Blocker for BPH **Key Point:** Tamsulosin is the most frequently prescribed alpha blocker for benign prostatic hyperplasia in India and worldwide due to its selectivity and tolerability profile. ### Why Tamsulosin Dominates Clinical Practice | Feature | Tamsulosin | Doxazosin | Phentolamine | Phenoxybenzamine | |---------|-----------|----------|--------------|------------------| | **Selectivity** | α1A-selective (prostate) | Non-selective α1 | Non-selective | Non-selective | | **Route** | Oral | Oral | IV/IM only | Oral | | **Indication** | BPH (approved) | BPH, hypertension | Pheochromocytoma | Pheochromocytoma | | **Adverse effects** | Minimal orthostasis | Orthostasis, dizziness | Severe orthostasis | Tachycardia, GI upset | | **Clinical use frequency** | Very common | Moderate | Rare (acute use) | Rare (chronic use) | **High-Yield:** Tamsulosin's α1A-selectivity for prostatic smooth muscle means: - Minimal vasodilation → **no significant orthostatic hypotension** - Better tolerability → **higher compliance** - Faster symptom relief → **preferred first-line agent** ### Why Other Options Are Less Common **Doxazosin:** Non-selective α1 antagonist; causes significant orthostatic hypotension and dizziness, limiting use. Reserved for patients with concurrent hypertension who need dual benefit. **Phentolamine & Phenoxybenzamine:** Non-selective, irreversible (phenoxybenzamine) or short-acting (phentolamine) agents used exclusively for **acute pheochromocytoma management**, not BPH. **Clinical Pearl:** The shift from non-selective (doxazosin, terazosin) to selective α1A blockers (tamsulosin, alfuzosin) represents a major pharmacological advance in BPH treatment, reducing side effects while maintaining efficacy. **Mnemonic:** **"TAM for BPH"** — **T**amsulosin is the **A**lpha blocker **M**ost used for BPH.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.